Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses CMPX in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named CMPX in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Thomas Schuetz | $630,000 | $381,150 | $0 | $4,065,000 | $0 | $0 | $21,000 | $5,097,150 |
| Chief Executive Officer | ||||||||
| Jonathan Anderman | 450,000 | 198,000 | — | 758,800 | — | — | — | 1,427,800 |
| General Counsel and Corporate Secretary | ||||||||
| Barry Shin | 480,000 | 216,000 | 0 | 677,500 | 0 | 0 | 21,000 | 1,394,500 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Thomas Schuetz | $5,097,150 | $3,093,057 | — | +2,004,093 |
| Jonathan Anderman | 1,427,800 | 893,635 | — | +534,165 |
| Barry Shin | 1,394,500 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Thomas Schuetz | RSU | 478,125 | — | $2,567,531 |
| Barry Shin | RSU | 300,000 | — | 1,611,000 |
| Thomas Schuetz | RSU | 250,000 | — | 1,342,500 |
| Thomas Schuetz | Option | 29,136 | 2.4 | — |
| Thomas Schuetz | Option | 204,144 | 3.93 | — |
| Thomas Schuetz | Option | 332,037 | 1.93 | — |
| Thomas Schuetz | Option | 1,187,500 | 3.65 | — |
| Barry Shin | Option | 300,000 | 1.65 | — |
| Barry Shin | Option | 197,910 | 3.65 | — |
| Jonathan Anderman | Option | 2,068 | 2.4 | — |
| Jonathan Anderman | Option | 23,322 | 3.93 | — |
| Jonathan Anderman | Option | 43,326 | 1.57 | — |
| Jonathan Anderman | Option | 200,000 | 1.2 | — |
| Jonathan Anderman | Option | 221,660 | 3.65 | — |
The company's compensation program reflects its growth and corporate goals, utilizing a combination of base salary, annual cash bonus, and long-term equity incentive compensation to align executive interests with stockholders in both the short- and long-term. The Board targets being competitive to peer companies and utilizes independent, third-party benchmarking to inform the level and mix of compensation.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Alpine Rewards |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-10 | 117,963,684 | 1,796,022 | 2,061,977 | 98.5% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-10 | 98.5%a |
a. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Carl L. GordonIndependent · Board Chair · Compensation (Chair) | $65,000 | $0 | $108,400 | — | — | $173,400 |
| Ellen V. ChiniaraIndependent · Audit · Nominating and Corporate Governance | 60,000 | 0 | 108,400 | — | — | 168,400 |
| Richard S. LindahlIndependent · Audit (Chair) | 55,000 | 0 | 108,400 | — | — | 163,400 |
| Philip J. FerneauIndependent · Nominating and Corporate Governance (Chair) · Compensation | 55,000 | 0 | 108,400 | — | — | 163,400 |
| James P. BoylanIndependent · Audit | 50,000 | 0 | 108,400 | — | — | 158,400 |
| Mary Ann GrayIndependent · Compensation | 45,000 | 0 | 108,400 | — | — | 153,400 |
| Thomas J. SchuetzEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $45,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 10,000 / 12,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $330,000 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $330,000 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Compass Therapeutics | 2025 | Thomas Schuetz | $630,000 | $0 | $4,065,000 | $0 | $5,097,150 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Thomas Schuetz | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Executive Compensation”. As printed: 5,097,150. Filing ↗machine: r2 · c21 · span 303582–303591 |
| 2 | Section 01, Jonathan Anderman | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Executive Compensation”. As printed: 1,427,800. Filing ↗ |
| 3 | Section 01, Barry Shin | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Executive Compensation”. As printed: 1,394,500. Filing ↗machine: r4 · c21 · span 311426–311435 |
| 4 | Section 08, Carl L. Gordon | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Director Compensation”. As printed: 173,400. Filing ↗machine: span 268365–268544 |
| 5 | Section 08, Ellen V. Chiniara | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Director Compensation”. As printed: 168,400. Filing ↗machine: span 265807–265986 |
| 6 | Section 08, Richard S. Lindahl | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Director Compensation”. As printed: 163,400. Filing ↗machine: span 275211–275389 |
| 7 | Section 08, Philip J. Ferneau | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Director Compensation”. As printed: 163,400. Filing ↗machine: span 270575–270754 |
| 8 | Section 08, James P. Boylan | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Director Compensation”. As printed: 158,400. Filing ↗machine: span 273134–273313 |
| 9 | Section 08, Mary Ann Gray | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Director Compensation”. As printed: 153,400. Filing ↗machine: span 263614–263793 |
| 10 | Section 08, Thomas J. Schuetz | DEF 14A | 2026-04-29 | 0001140361-26-017649 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 11 | Section 06, 2026 vote | Form 8-K | 2026-06-11 | 0001171843-26-004068 | Item 5.07 · say-on-pay result. As reported: 98.5% (votes for as printed: 117,963,684). Filing ↗ |
| 12 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 13 | Section 09b board cost (computed) | Computed | — | computed | Cash 330,000 + equity 0 + all other 0 = 330,000, summed across the director compensation table rows.machine: formula: Σ = 330,000 |
| 14 | Compass Therapeutics (subject), Section 10b CEO total | DEF 14A | 2026-04-29 | 0001140361-26-017649 | CEO total compensation as printed in Compass Therapeutics's own proxy. As printed: 5,097,150. Filing ↗machine: r2 · c21 · span 303582–303591 |